IBDEI147 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17901,1,4,0)
 ;;=4^G31.83
 ;;^UTILITY(U,$J,358.3,17901,2)
 ;;=^329888
 ;;^UTILITY(U,$J,358.3,17902,0)
 ;;=F01.51^^88^899^30
 ;;^UTILITY(U,$J,358.3,17902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17902,1,3,0)
 ;;=3^Vascular Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,17902,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,17902,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,17903,0)
 ;;=F01.50^^88^899^31
 ;;^UTILITY(U,$J,358.3,17903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17903,1,3,0)
 ;;=3^Vascular Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,17903,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,17903,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,17904,0)
 ;;=A81.9^^88^899^6
 ;;^UTILITY(U,$J,358.3,17904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17904,1,3,0)
 ;;=3^Atypical Virus Infection of CNS,Unspec
 ;;^UTILITY(U,$J,358.3,17904,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,17904,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,17905,0)
 ;;=A81.09^^88^899^8
 ;;^UTILITY(U,$J,358.3,17905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17905,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease NEC
 ;;^UTILITY(U,$J,358.3,17905,1,4,0)
 ;;=4^A81.09
 ;;^UTILITY(U,$J,358.3,17905,2)
 ;;=^5000410
 ;;^UTILITY(U,$J,358.3,17906,0)
 ;;=A81.00^^88^899^9
 ;;^UTILITY(U,$J,358.3,17906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17906,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Unspec
 ;;^UTILITY(U,$J,358.3,17906,1,4,0)
 ;;=4^A81.00
 ;;^UTILITY(U,$J,358.3,17906,2)
 ;;=^5000409
 ;;^UTILITY(U,$J,358.3,17907,0)
 ;;=A81.01^^88^899^10
 ;;^UTILITY(U,$J,358.3,17907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17907,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Variant
 ;;^UTILITY(U,$J,358.3,17907,1,4,0)
 ;;=4^A81.01
 ;;^UTILITY(U,$J,358.3,17907,2)
 ;;=^336701
 ;;^UTILITY(U,$J,358.3,17908,0)
 ;;=A81.89^^88^899^7
 ;;^UTILITY(U,$J,358.3,17908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17908,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,17908,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,17908,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,17909,0)
 ;;=A81.2^^88^899^27
 ;;^UTILITY(U,$J,358.3,17909,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17909,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,17909,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,17909,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,17910,0)
 ;;=B20.^^88^899^17
 ;;^UTILITY(U,$J,358.3,17910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17910,1,3,0)
 ;;=3^HIV Disease w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,17910,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,17910,2)
 ;;=^5000555^F02.81
 ;;^UTILITY(U,$J,358.3,17911,0)
 ;;=B20.^^88^899^18
 ;;^UTILITY(U,$J,358.3,17911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17911,1,3,0)
 ;;=3^HIV Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,17911,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,17911,2)
 ;;=^5000555^F02.80
 ;;^UTILITY(U,$J,358.3,17912,0)
 ;;=F10.27^^88^899^1
 ;;^UTILITY(U,$J,358.3,17912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17912,1,3,0)
 ;;=3^Alcohol Dependence w/ Alcohol-Induced Persisting Dementia
 ;;^UTILITY(U,$J,358.3,17912,1,4,0)
 ;;=4^F10.27
 ;;^UTILITY(U,$J,358.3,17912,2)
 ;;=^5003095
 ;;^UTILITY(U,$J,358.3,17913,0)
 ;;=F19.97^^88^899^29
 ;;^UTILITY(U,$J,358.3,17913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17913,1,3,0)
 ;;=3^Psychoactive Substance Use w/ Persisting Dementia NEC
